A New Way to Catch Up with ASH News and Reports: The Hematologist Podcasts
To better serve the Society’s membership by bringing new digital offerings, The Hematologist has launched its first podcast! The Hematologist, as one of ASH’s most visible and valued member benefits, provides fertile ground for these offerings.
The inaugural podcast, “Navigating Future Challenges in Lymphoma” features a conversation with Ann LaCasce, MD, and David Weinstock, MD, about the strategic roadmap for lymphoma research recently published in Blood, moderated by The Hematologist Editor-in-Chief Jason Gotlib, MD, MS. Thus far, more than 200 listeners from 40 countries have tuned in.
Future podcast topics are already in the works, with the popular “Diffusion” articles – a selection of concise and provocative digests of major
breakthrough articles recently published in world literature related to the field of hematology – next in line for audio commentary. In a podcast to coincide with the July/August 2015 issue, Contributing Editor David Garcia, MD, will be discussing new research on anticoagulation therapy in patients with high-risk pulmonary embolism.
The podcasts are available to stream or download on ASH’s SoundCloud page. Listeners can also download the SoundCloud mobile app from the Google Play or App Store to listen on their mobile device.
ASH Submits Comments on USPSTF Draft Recommendation Statements on Iron Deficiency Anemia
On April 27, 2015, ASH submitted comments to the U.S. Preventive Services Task Force (USPSTF) in response to its draft recommendation statements on “Iron Deficiency Anemia in Pregnant Women: Screening and Supplementation, 2016” and “Iron Deficiency Anemia in Young Children: Screening and Supplementation.”
The USPSTF draft recommendation statements outline the importance of gathering more information about iron deficiency anemia in
these populations to develop better screening and prevention methods.
ASH’s comment letter states that the Society agrees the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency anemia in young children and pregnant women; however, ASH urges the USPSTF to add a clear statement to the recommendations indicating that in the absence of sufficient data, decisions regarding iron screening and supplementation should be individualized and left to the judgement of the involved clinicians and their patients.
ASH’s letter also encourages USPSTF to clarify the meaning of the recommendation grading system, define symptoms of iron deficiency and
at-risk children, add information about the use of IV iron versus oral iron supplements, and explain the difference between the USPSTF recommendation and other national recommendations on screening for iron deficiency.
Read the full text of ASH’s comment letter here.
Improving MDS Outcomes from Diagnosis to Treatment: A Multidisciplinary Approach
ASH is co-sponsoring a complimentary CME summit on myelodysplastic syndrome (MDS), focusing on the multidisciplinary approach to care for MDS patients. The American Society for Clinical Pathology and the France Foundation are co-hosting these workshops.
The goal of this summit is to improve performance diagnosis and treatment of MDS patients. Participants will actively engage in multidisciplinary, interactive small-group activities, including:
- Case-based tumor board discussions
- Assessing low or high grade MDS
- Acquiring of morphologic mimics
- Applying the prognostic scoring system to cytogenetics
- Identifying the new role of molecular testing
The summit is designed for all members of the MDS care team, including: hematologists, pathologists, medical laboratory scientists, medical oncologists, and hematology/oncology nurse practitioners and physician assistants.
The one-day MDS workshop is being offered at three locations:
- Chicago, IL – Thursday, September 17, 2015
- New York, NY – Friday, October 9, 2015
- Tampa, FL – Friday, October 16, 2015
Register for the summit and view the complete agenda here.